Bedfont® are thrilled to announce a new partnership with Geratherm® Group

FHS
August 21, 2024
12:45 pm

New study offers preliminary estimates of mortality risk by stage in Alzheimer’s disease

Researchers examine the expected survival of people at each stage of Alzheimer’s disease.

August 17, 2023

The Trip Report by Beckley Waves Launches The Trip Report Podcast | Psychedelic Invest

The Trip Report by Beckley Waves, a leading publication on the business, science, policy and cultural impact of the nascent psychedelic field, is announcing the

August 4, 2023

Glaukos eyes FDA approval for ocular therapy after Phase III win

Epioxa was developed to be used during the corneal cross-linking procedure to treat keratoconus. Credit: MacroEcon/Shutterstock. Glaukos plans to file for US approval of its

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.